4//SEC Filing
Sandercock Colin 4
Accession 0000899243-21-006355
CIK 0001645460other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:43 PM ET
Size
5.3 KB
Accession
0000899243-21-006355
Insider Transaction Report
Form 4
Sandercock Colin
SVP, GENERAL COUNSEL
Transactions
- Award
Stock Option (right to buy)
2021-02-10+50,000→ 50,000 totalExercise: $15.55Exp: 2031-02-09→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 10, 2021.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001724870
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 5:43 PM ET
- Size
- 5.3 KB